SENSEX NIFTY

Glenmark Pharmaceuticals

Aug 26, 2014 at 15:25 | Source: Moneycontrol.com
According to a Quant report, most pharma companies continue to have strong ANDA filings pending for approval, which gives enough confidence of high long-term growth, subject to timely regulatory approval.
Aug 25, 2014 at 11:12 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips.in, technology sector will be receiving strong astrological support and advises buyingg Tata Consultancy Services, Tech Mahindra, Infosys, HCL Technologies, Polaris Financial Technology, Geometric, Mastek and CMC.
Aug 25, 2014 at 11:02 | Source: Moneycontrol.com
The brokerage downgraded the stock to underperform with a new target price of Rs 710 as it believes the stock is fully valued at target FY16E P/E of 18 times.
Aug 22, 2014 at 21:45 | Source: Moneycontrol.com
Glenmark Pharmaceuticals has informed that the Operations Committee of the Board of Directors of the Company, at its Meeting held on August 22, 2014 allotted 14,750 shares to the employees of the Company on exercise of options granted to them pursuant to ESOS 2003.
Aug 22, 2014 at 15:36 | Source: CNBC-TV18
Surajit Pal picks Glenmark as his top pharma bet among midcaps.
Aug 21, 2014 at 15:35 | Source: CNBC-TV18
Arvind Bothra picks Aurobindo Pharma as his favourite bet among midcaps and Sun Pharma and Lupin among large caps.
Aug 20, 2014 at 15:26 | Source: Moneycontrol.com
Marksans Pharma surged 7 percent (up 200 percent year-to-date) while Orchid Chemicals gained 9 percent as it expects to increase capacity utilisation to 90-100 percent by end of this year.
Aug 20, 2014 at 13:18 | Source: CNBC-TV18
Here are few top buzzing stocks picked by CNBC-TV18's analysts in trade today - Dena Bank, Oriental Bank of Commerce (OBC), Eros International Media, Orchid Chemicals, Ipca Laboratories, Glenmark, International Paper, Arvind Mills and Atul.
Aug 20, 2014 at 11:29 | Source: Moneycontrol.com
GBR 1302 was discovered and developed by Glenmark Biologics Research Centre located in La Chaux-de-Fonds, Switzerland and would be first molecule to could become a patented molecule or drug for the company once it goes through multiple stages of research and development.
Aug 20, 2014 at 11:23 | Source: CNBC-TV18
GBR 1302 molecule is a genetically engineered molecule and will be used for the study of breast cancer, says Michael Buschle.
Messages on Glenmark Pharmaceuticals »

BSE/NSE Announcer

Platinum Member

4041 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding the press release dated July 08, 2014 titled,"Glenmark Generics receives final ANDA approval for Telmisartan Tablets."

12.41 PM Jul 8th

BSE/NSE Announcer

Platinum Member

4041 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets" Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from

12.04 PM Jul 8th

phs25

Gold Member

9 Followers

Glenmark  

Glenmark Generics receives final ANDA approval for Telmisartan Tablets | 07/08/14 12:01 Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets

12.03 PM Jul 8th

BSE/NSE Announcer

Platinum Member

4041 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014.

11.48 AM Jul 8th

BSE/NSE Announcer

Platinum Member

4041 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has submitted to the Exchange a copy of press release dated July 03, 2014 titled "Glenmarks novel monoclonal antibody GBR 830 for treatment of autoimmune diseases entering human trials"

5.57 PM Jul 3rd

BSE/NSE Announcer

Platinum Member

4041 Followers

Glenmark  

The Register of Members & Share Transfer Books of Glenmark Pharmaceuticals will remain closed from July 14, 2014 to July 25, 2014 (both days inclusive) for the purpose of Payment of Dividend & 36th Annual General Meeting (AGM) of the Company to be held on July 25, 2014.

7.05 PM Jun 30th

adviserbola

Platinum Member

218 Followers

Marksans Pharma  

Did any body know Before promoting this venture Marksans Pharma, Mr. Mark Saldanha held the position of whole time Director at Glenmark Pharmaceuticals Ltd. Today Glenmark Pharma is trading above 570 Levels

10.32 PM Jun 11th

Jayan C

New Member

6 Followers

Just Posted  

Glenmark Pharmaceuticals has opened its new monoclonal antibody manufacturing facility in La Chaux-de-Fonds, Switzerland.

6.22 PM Jun 5th

Amrita Gaba

New Member

413 Followers

Glenmark  

Glenmark Pharmaceuticals S.A (GPSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd. has opened its new GMP compliant monoclonal antibody manufacturing facility in La Chaux-de- Fonds, Switzerland. This manufacturing facility supplements Glenmark`s existing in-house discovery

12.57 PM Jun 5th

BSE/NSE Announcer

Platinum Member

4041 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated June 04, 2014, titled"Glenmark Pharmaceuticals Inaugurates new Antibody Manufacturing Facility in La Chaux-de fonds, Switzerland".

11.11 AM Jun 4th

News across the web »
Aug 21, 2014 at 09:37 | Source: Calcutta Telegraph News
May 09, 2014 at 10:56 | Source: Economic Times
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.